Trial Profile
Study to compare the efficacy of abatacept versus tocilizumab in patients with rheumatoid arthritis in clinical practice.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 Aug 2015 Results published in the Annals of the Rheumatic Diseases.
- 29 Jul 2015 New trial record
- 13 Jun 2015 Results from a propensity-score matching analysis presented at the 16th Annual Congress of the European League Against Rheumatism.